The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol

Sarosh Khan, Samer Fawaz, Rupert Simpson, Craig Robertson, Paul Kelly, Shah Mohdnazri, Kare Tang, Christopher M. Cook, Sean Gallagher, Peter O’Kane, James Spratt, Emmanouil S. Brilakis, Grigoris V. Karamasis, Rasha Al-Lamee, Thomas R. Keeble, John R. Davies

Research output: Contribution to journal › Article › peer-review